GATC Health vs Tempus
Side-by-side comparison of AI visibility scores, market position, and capabilities
GATC Health uses its Multiomics Advanced Technology (MAT) platform to simulate human biochemistry and accelerate drug discovery; its AI achieves 86% sensitivity and 91% specificity in university validation studies.
About
GATC Health is a tech-bio company that applies artificial intelligence and multi-omics science to transform drug discovery and development. The company''s proprietary Multiomics Advanced Technology (MAT) platform integrates genomics, transcriptomics, proteomics, and metabolomics data to simulate billions of interactions in human biochemistry — enabling rapid identification of drug targets, prediction of drug efficacy and toxicity, and optimization of therapeutic candidates before in vitro or in vivo testing begins.
Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.
About
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.